Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;27(3):e307-e312.
doi: 10.3747/co.27.5707. Epub 2020 Jun 1.

Barriers to conducting cancer trials in Canada: an analysis of key informant interviews

C Bentley  1   2 , S Sundquist  3   4 , J Dancey  3   4   5   6 , S Peacock  1   2   7
Affiliations

Barriers to conducting cancer trials in Canada: an analysis of key informant interviews

C Bentley et al. Curr Oncol. 2020 Jun.

Abstract

Background: In Canada, there is growing evidence that oncology clinical trials units (ctus) and programs face serious financial challenges. Investment in cancer research in Canada has declined almost 20% in the 5 years since its peak in 2011, and the costs of conducting leading-edge trials are rising. Clinical trials units must therefore be strategic about which studies they open. We interviewed Canadian health care professionals responsible for running cancer trials programs to identify the barriers to sustainability that they face.

Methods: One-on-one telephone interviews were conducted with clinicians and clinical research professionals at oncology ctus in Canada. We asked for their perspectives about the barriers to conducting trials at their institutions, in their provinces, and nationwide. Interviews were digitally recorded, transcribed, anonymized, and coded in the NVivo software application (version 11: QSR International, Melbourne, Australia). The initial coding structure was informed by the interview script, with new concepts drawn out and coded during analysis, using a constant comparative approach.

Results: Between June 2017 and November 2018, 25 interviews were conducted. Key barriers that participants identified were■ insufficient stable funding to support trials infrastructure and retain staff;■ the need to adopt strict cost-recovery policies, leading to fewer academic trials in portfolios; and■ an overreliance on industry to fund clinical research in Canada.

Conclusions: Funding uncertainties have led ctus to increasingly rely on industry sponsorship and more stringent feasibility thresholds to remain solvent. Retaining skilled trials staff can create efficiencies in opening and running studies, with spillover effects of more trials being open to patients. More academic studies are needed to curb industry's influence.

Keywords: Canada; Clinical trials; clinical trials units; oncology research investment; sustainability.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST DISCLOSURES We have read and understood Current Oncology’s policy on disclosing conflicts of interest, and we declare the following interests: JD’s and SS’s institution provided funding for this study. CB and SP have no conflicts of interest to declare.

References

    1. Bertagnolli MM, Canetta R, Nass SJ. Expanding public–private collaborations to enhance cancer drug development: a report of the Institute of Medicine’s workshop series, “Implementing a National Cancer Clinical Trials System for the 21st Century”. Oncologist. 2014;19:1179–85. doi: 10.1634/theoncologist.2014-0240. - DOI - PMC - PubMed
    1. Kasenda B, Schandelmaier S, Sun X, et al. on behalf of the disco study group. Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications. BMJ. 2014;349:g4539. doi: 10.1136/bmj.g4539. - DOI - PMC - PubMed
    1. Bentley C, Cressman S, van der Hoek K, Arts K, Dancey J, Peacock S. Conducting clinical trials: costs, impacts, and the value of clinical trials networks—a scoping review. Clin Trials. 2019;16:183–93. doi: 10.1177/1740774518820060. - DOI - PubMed
    1. Moses H, 3rd, Matheson DH, Cairns-Smith S, George BP, Palisch C, Dorsey ER. The anatomy of medical research: US and international comparisons. JAMA. 2015;313:174–89. doi: 10.1001/jama.2014.15939. - DOI - PubMed
    1. Canadian Cancer Research Alliance (ccra) Cancer Research Investment in Canada, 2016. Toronto, ON: Canadian Partnership Against Cancer; 2019. [Available online at: https://www.ccra-acrc.ca/wp-content/uploads/2019/06/Investment_Report_20...; cited 5 August 2019]

Publication types